QUEST DIAGNOSTICS INC shareholders Q2 2023

QUEST DIAGNOSTICS INC's ticker is DGX and the CUSIP is 74834L100. A total of 804 filers reported holding QUEST DIAGNOSTICS INC in Q2 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

QUEST DIAGNOSTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Freedom Investment Management, Inc. 8,036$1,129,6090.13%
FIRST TRUST ADVISORS LP 778,654$109,447,5810.12%
Tower Research Capital LLC (TRC) 26,230$3,686,8890.12%
Bridgewater Associates 139,413$19,595,8910.12%
EADS & HEALD WEALTH MANAGEMENT 1,743$2450.12%
Cypress Capital Management LLC (WY) 765$107,5280.12%
Bell & Brown Wealth Advisors, LLC 1,690$237,5460.12%
ATLAS CAPITAL ADVISORS LLC 5,603$787,5570.12%
Retirement Systems of Alabama 187,956$26,419,0950.12%
VIRGINIA RETIREMENT SYSTEMS ET AL 87,072$12,238,8400.12%
VALLEY NATIONAL ADVISERS INC 4,924$6930.12%
PARSONS CAPITAL MANAGEMENT INC/RI 10,770$1,513,8320.12%
Rothschild Capital Partners, LLC 2,222$312,3240.12%
New Hampshire Trust 3,108$436,8600.11%
CONTRAVISORY INVESTMENT MANAGEMENT, INC. 3,064$430,6760.11%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 2,350$3300.11%
GIRARD PARTNERS LTD. 7,516$1,056,5620.11%
Legacy Financial Advisors, Inc. 4,252$597,6760.11%
Corton Capital Inc. 1,689$237,4060.11%
EXENCIAL WEALTH ADVISORS, LLC 17,276$2,428,2780.11%
About QUEST DIAGNOSTICS INC

Quest Diagnostics Inc. is a leading provider of diagnostic information services. The company offers a wide range of services, including clinical laboratory testing, diagnostic imaging, and information technology solutions. Quest Diagnostics operates in the United States, serving patients and healthcare providers across the country.

The company has a strong reputation for quality and accuracy, with a focus on providing timely and reliable results. Quest Diagnostics has a team of highly trained professionals who use the latest technology and techniques to deliver accurate and actionable information to patients and healthcare providers.

Quest Diagnostics has a strong financial position, with a solid balance sheet and a history of consistent growth. The company has a market capitalization of over $15 billion and generates annual revenues of more than $7 billion.

Quest Diagnostics is led by a team of experienced executives, including CEO Steve Rusckowski and CFO Mark Guinan. The company has a strong commitment to innovation and is constantly exploring new ways to improve its services and expand its offerings.

Overall, Quest Diagnostics is a well-respected and successful company that is poised for continued growth and success in the years ahead. With a focus on quality, accuracy, and innovation, Quest Diagnostics is a leader in the diagnostic information services industry and a valuable partner for patients and healthcare providers alike.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

External links

This page lists QUEST DIAGNOSTICS INC's shareholders in Q2 2023. To view QUEST DIAGNOSTICS INC's shareholder history, click here.